BLU-847

N/A

Report date: 2025/01/26 16:40:32

NME

Base Information

Drug NameBLU-847

Drug Alias NameTrkA/TrkB/TrkC inhibitor (Blueprint Medicines)BLU-847

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNerve growth factor receptor Trk-A antagonistsNeurotrophic tyrosine kinase receptor type 3 inhibitorsNeurotrophic tyrosine kinase receptor type 2 inhibitors

TargetsNeurotrophic tyrosine kinase receptor type 3Nerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBlueprint Medicines Corp

China Registration ClassN/A

Develop Information

Active CompaniesBlueprint Medicines Corp

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A